Adicet Bio (ACET) Net Shares Issued and Repurchased (2017 - 2026)

Adicet Bio has reported Net Shares Issued and Repurchased for 10 years, with the latest figure at $867811.0 in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 81.15% year-over-year to $867811.0 in Q1 2026; TTM through Mar 2026 was $867811.0, a 81.15% decrease from a year earlier, with the FY2025 full-year figure at $510761.0, down 93.23% from the prior year.
• Net Shares Issued and Repurchased was $867811.0 for Q1 2026 at Adicet Bio, up from $510761.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $7.5 million in Q4 2024, with the low at $510761.0 in Q4 2025.
• Average Net Shares Issued and Repurchased over 5 years is $3.1 million, with a median of $2.7 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased surged 75.83% in 2024, then plunged 93.23% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.7 million in 2022, then soared by 59.46% to $4.3 million in 2023, then soared by 75.83% to $7.5 million in 2024, then slumped by 93.23% to $510761.0 in 2025, then surged by 69.91% to $867811.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $867811.0 (Q1 2026), $510761.0 (Q4 2025), and $4.6 million (Q1 2025), per Business Quant data.